CSNK2A3 anticorps (AA 151-391) (FITC)
-
- Antigène Tous les produits CSNK2A3
- CSNK2A3 (Casein Kinase 2, alpha 3 Polypeptide (CSNK2A3))
-
Épitope
- AA 151-391
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CSNK2A3 est conjugé à/à la FITC
- Application
- Veuillez nous consulter SVP
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Casein kinase II subunit alpha 3 protein (151-391AA)
- Isotype
- IgG
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- CSNK2A3 (Casein Kinase 2, alpha 3 Polypeptide (CSNK2A3))
- Autre désignation
- CSNK2A3 (CSNK2A3 Produits)
- Synonymes
- anticorps CK II alpha 3, anticorps CSNK2A1P, anticorps casein kinase 2 alpha 3, anticorps CSNK2A3
- Sujet
-
Background: Probable catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Amplification-dependent oncogene, promotes cell proliferation and tumorigenesis by down-regulating expression of the tumor suppressor protein, PML. May play a role in the pathogenesis of the lung cancer development and progression.
Aliases: CSNK2A3 antibody, CSNK2A1PCasein kinase II subunit alpha 3 antibody, CK II alpha 3 antibody, EC 2.7.11.1 antibody, Casein kinase II alpha 1 polypeptide pseudogene antibody
- UniProt
- Q8NEV1
-